IMETRIGO Trademark

Trademark Overview

On Tuesday, March 17, 2020, a trademark application was filed for IMETRIGO with the United States Patent and Trademark Office. The USPTO has given the IMETRIGO trademark a serial number of 88837531. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 13, 2023. This trademark is owned by Genentech, Inc.. The IMETRIGO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical oncology preparations
imetrigo

General Information

Serial Number88837531
Word MarkIMETRIGO
Filing DateTuesday, March 17, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 17, 2020

Trademark Statements

Goods and ServicesPharmaceutical oncology preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, March 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, February 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, December 2, 2022ASSIGNED TO EXAMINER
Thursday, August 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 25, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 8, 2022SOU EXTENSION 3 GRANTED
Friday, July 8, 2022SOU EXTENSION 3 FILED
Friday, July 8, 2022TEAS EXTENSION RECEIVED
Wednesday, December 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 6, 2021SOU EXTENSION 2 GRANTED
Monday, December 6, 2021SOU EXTENSION 2 FILED
Monday, December 6, 2021TEAS EXTENSION RECEIVED
Friday, June 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 16, 2021SOU EXTENSION 1 GRANTED
Wednesday, June 16, 2021SOU EXTENSION 1 FILED
Wednesday, June 16, 2021TEAS EXTENSION RECEIVED
Monday, April 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 19, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 28, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 10, 2020NON-FINAL ACTION E-MAILED
Friday, April 10, 2020NON-FINAL ACTION WRITTEN
Friday, April 10, 2020ASSIGNED TO EXAMINER
Saturday, March 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 20, 2020NEW APPLICATION ENTERED

Related Keywords

imetrigo preparations oncology pharmaceutical